Physical clotting matrix

“Physical clotting matrix” is a descriptive term rather than a canonical molecular target. It refers to the meshwork, primarily of fibrin, formed at a site of vascular injury during the process of hemostasis to stop bleeding. This matrix incorporates platelets, red blood cells, plasma proteins, and a network of fibrin fibers polymerized from fibrinogen via the action of thrombin, and stabilized by factor XIII[3][5]. In medicine, “physical clotting matrix” often refers to either the natural fibrin clot produced by the coagulation cascade or to artificial hemostatic materials (cellulose, gelatin, starch, collagen) engineered to mimic or enhance this natural barrier in surgical or trauma settings[9]. This matrix’s physical properties—such as density, porosity, and fiber thickness—are influenced by thrombin generation patterns, factor concentrations, and disease states[3]. It is not a molecule, receptor, or enzyme and thus is not considered a canonical therapeutic target[1][3][9]. Rather, it is the structural endpoint of hemostasis and a physical substrate used or mimicked by hemostatic agents to control bleeding[9]. Because “physical clotting matrix” is not a molecule, protein, or specific biological target, but a material or composite structure, it falls outside the usual types of drug targets (e.g., receptor, enzyme) and is best categorized as “Other.”

Other names

Hemostatic matrixClot matrixFibrin clot matrixPhysical hemostatic matrix

Provides a *physical matrix* at a bleeding site to concentrate blood components and facilitate normal clot formation, regardless of the patient’s coagulation factor status[9]; Enhances barrier formation at the site of vascular injury; Supports the body’s intrinsic hemostatic mechanisms